[HTML][HTML] Examination of the novel sigma-1 receptor antagonist, SI 1/28, for antinociceptive and anti-allodynic efficacy against multiple types of nociception with fewer …
LL Wilson, SO Eans, I Ramadan-Siraj… - International Journal of …, 2022 - mdpi.com
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer …
LL Wilson, SO Eans, I Ramadan-Siraj… - … Journal of Molecular …, 2022 - europepmc.org
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer …
LL Wilson, SO Eans, I Ramadan-Siraj, MN Modica… - agris.fao.org
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer …
LL Wilson, SO Eans, I Ramadan-Siraj… - International …, 2022 - search.ebscohost.com
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer …
LL Wilson, SO Eans… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
[HTML][HTML] Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with …
LL Wilson, SO Eans, I Ramadan-Siraj… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
[PDF][PDF] Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer …
LL Wilson, SO Eans, I Ramadan-Siraj, MN Modica… - Int. J. Mol. Sci, 2022 - iris.unict.it
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer …
LL Wilson, SO Eans, I Ramadan-Siraj… - International …, 2022 - search.proquest.com
Neuropathic pain is a significant problem with few effective treatments lacking adverse
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …
effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as …